Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy H Perlis

Showing results (241-250 of 414) with videos related to

Pageof 42
Sort By:
Harvard Review of Psychiatry|March 19, 2002
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practiceRoy H Perlis, Maurizio Fava, Andrew A Nierenberg, et al.
Biological Psychiatry|June 14, 2005
Molecular genetics of attention-deficit/hyperactivity disorderStephen V Faraone, Roy H Perlis, Alysa E Doyle, et al.
JAMA Network Open|July 31, 2024
Trust in Physicians and Hospitals During the COVID-19 Pandemic in a 50-State Survey of US AdultsRoy H Perlis, Katherine Ognyanova, Ata Uslu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Generalizability of Risk Models for Treatment-Resistant Depression Across Three Health SystemsColin G Walsh, Michael Ripperger, Thomas H McCoy, et al.
The American Journal of Psychiatry|May 19, 2025
Stratifying Risk for Postpartum Depression at Time of Hospital DischargeMark A Clapp, Victor M Castro, Pilar Verhaak, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2008
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D studyRoy H Perlis, Priya Moorjani, Jesen Fagerness, et al.
Biological Psychiatry|October 4, 2005
Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHDJordan W Smoller, Joseph Biederman, Lori Arbeitman, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trialRoy H Perlis, Robert W Baker, Carlos A Zarate, et al.
Human Heredity|August 19, 2011
Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood frameworkPhil H Lee, Sarah E Bergen, Roy H Perlis, et al.
Depression and Anxiety|August 31, 2012
Self-report and clinician-rated measures of depression severity: can one replace the other?Rudolf Uher, Roy H Perlis, Anna Placentino, et al.
Pageof 42

Showing results (241-250 of 414) with videos related to

Sort By:
Pageof 42
Harvard Review of Psychiatry|March 19, 2002
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practiceRoy H Perlis, Maurizio Fava, Andrew A Nierenberg, et al.
Biological Psychiatry|June 14, 2005
Molecular genetics of attention-deficit/hyperactivity disorderStephen V Faraone, Roy H Perlis, Alysa E Doyle, et al.
JAMA Network Open|July 31, 2024
Trust in Physicians and Hospitals During the COVID-19 Pandemic in a 50-State Survey of US AdultsRoy H Perlis, Katherine Ognyanova, Ata Uslu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Generalizability of Risk Models for Treatment-Resistant Depression Across Three Health SystemsColin G Walsh, Michael Ripperger, Thomas H McCoy, et al.
The American Journal of Psychiatry|May 19, 2025
Stratifying Risk for Postpartum Depression at Time of Hospital DischargeMark A Clapp, Victor M Castro, Pilar Verhaak, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2008
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D studyRoy H Perlis, Priya Moorjani, Jesen Fagerness, et al.
Biological Psychiatry|October 4, 2005
Association between the 5HT1B receptor gene (HTR1B) and the inattentive subtype of ADHDJordan W Smoller, Joseph Biederman, Lori Arbeitman, et al.
The Journal of Clinical Psychiatry|January 2, 2007
Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trialRoy H Perlis, Robert W Baker, Carlos A Zarate, et al.
Human Heredity|August 19, 2011
Modifiers and subtype-specific analyses in whole-genome association studies: a likelihood frameworkPhil H Lee, Sarah E Bergen, Roy H Perlis, et al.
Depression and Anxiety|August 31, 2012
Self-report and clinician-rated measures of depression severity: can one replace the other?Rudolf Uher, Roy H Perlis, Anna Placentino, et al.
Pageof 42